Notes from Underground: Are cognitive-enhancing drugs respecting their promises?
Cognitive deficits are increasingly acknowledged as a highly relevant clinical feature of schizophrenia, susceptible of therapeutic intervention. Considerable efforts have been devoted to identify and develop pharmacological agents that provide cognitive-enhancing benefits to patients with schizophr...
Main Authors: | Frank Larøi, Andrea Raballo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2010-09-01
|
Series: | Frontiers in Psychology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fpsyg.2010.00158/full |
Similar Items
-
A esquizofrenia e seu tratamento farmacológico
by: Cilene Rejane Ramos Alves, et al. -
Case of Secondary Tics Associated With Olanzapine in an Adult
by: Eric W. Mills, et al.
Published: (2017-08-01) -
Editorial: Thinking Through the Schizophrenia Spectrum: Nosological Scenarios and Perspectives Beyond Psychosis
by: Anna Comparelli, et al.
Published: (2021-10-01) -
Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia
by: Kristian S. Hill, et al.
Published: (2009-04-01) -
Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients
by: Dieter Naber, et al.
Published: (2009-10-01)